Oncogenes were detected in 64% of lung adenocarcinomas [2], while available information in relation to EGFR, BRAF, KRAS, ALK, ROS1, and MET gene mutations in lung adenocarcinomas are growing steadily. This evidence concerns the gene MET and lung adenocarcinoma.